|Numéro de publication||US20070005083 A1|
|Type de publication||Demande|
|Numéro de demande||US 11/515,181|
|Date de publication||4 janv. 2007|
|Date de dépôt||1 sept. 2006|
|Date de priorité||30 avr. 1997|
|Autre référence de publication||EP1157663A1, US7670373, US8136520, US20100114157, WO1998048706A1|
|Numéro de publication||11515181, 515181, US 2007/0005083 A1, US 2007/005083 A1, US 20070005083 A1, US 20070005083A1, US 2007005083 A1, US 2007005083A1, US-A1-20070005083, US-A1-2007005083, US2007/0005083A1, US2007/005083A1, US20070005083 A1, US20070005083A1, US2007005083 A1, US2007005083A1|
|Inventeurs||Sabaratham Sabanathan, Thirumani Sabanathan|
|Cessionnaire d'origine||Sabaratham Sabanathan, Thirumani Sabanathan|
|Exporter la citation||BiBTeX, EndNote, RefMan|
|Citations de brevets (99), Référencé par (60), Classifications (18), Événements juridiques (2)|
|Liens externes: USPTO, Cession USPTO, Espacenet|
This application is a continuation of co-pending U.S. patent application Ser. No. 09/762,692, entitled “Occlusion Device”, filed Oct. 31, 2005, which is the National Stage of International PCT Application No. PCT/GB98/00652, entitled “Occlusion Device”, filed Mar. 3, 1998, which claims the benefit of priority to U.K. Patent Application No. 9708681.3, entitled “Lung Treatment Device”, filed Apr. 30, 1997. Disclosures of the aforementioned patent applications are hereby incorporated by reference in their entirety.
The present invention relates to a device useful in the treatment of emphysema and other diseases or disorders of the human or animal lung.
Emphysema is a disease of the lung caused primarily by prolonged smoking, although not exclusively thereby. It is an unrelentless, intractable and debilitating process. Emphysema is defined as an abnormal permanent enlargement of the air spaces distal to the terminal bronchioles, accompanied by destruction of their walls without obvious fibrosis. In this context, destruction means non-uniformity in the pattern of respiratory,airspace enlargement; orderly appearance of the acinus is disturbed and may be lost.
Emphysema causes a physiological loss of lung elastic recoil, which decreases expiratory airflow by loss of driving pressure and premature airway closure from reduced airway traction. The effect of this is that the alveoli become hyper-inflated without there being any real exchange of air with the outside. Therefore the patient begins to feel starved of oxygen and so attempts to breathe more deeply. In breathing more deeply, the effects are exacerbated.
Not only are those individual alveoli which have a block in their respective bronchial tubules affected, but also neighbouring alveoli, perhaps in other regions of the lung, which may otherwise be perfectly serviceable, become affected because the hyper-inflated alveoli pressurise neighbouring alveoli and prevent them from expanding fully. There is, of course, a relatively fixed “exchange” volume of an individual's lung, that is to say, the difference between the expanded volume and the deflated volume. Emphysema reduces the exchange volume because undeflated alveoli occupy that space. Consequently, the only recourse available to the patient is to increase the expanded volume, thereby resulting in the barrel chest symptomatic of emphysema sufferers.
The major therapeutic modalities currently available consist of bronchodilator and anti-inflammatory drugs, directed at decreasing airway resistance, and antibiotics to treat acute and chronic infection. Supplemental oxygen therapy for the hypoxaemic patient improves exercise performance and improves survival in patients with cor pulmonale. Despite all available medical therapies, the course of the disease is one of progressive limitation, increasing dyspnoea and significant increase in overall mortality.
It has long been realised that full lung volume is more than enough for survival in most circumstances and that a person can survive quite satisfactorily with only one lung, for example. Heterogenous distribution of emphysema, together with the lack of pulmonary blood flow to those areas have made lung volume reduction surgery a logical option. Removal of parts of the lung affected by emphysema permits unaffected areas to become operative again and so enable a better quality of life for the patient. Clearly, however, such invasive procedures are of a very serious nature and some patients will not, in any event, be in a sufficiently strong condition to accept the trauma of such procedures. Primarily, the basic relief for emphysema sufferers is inactivity, on the one hand, and breathing pure oxygen, on the other.
Emphysema is a distressing condition affecting a relatively large proportion of the population, and a more effective and less traumatic treatment is required.
On a different matter, other lung conditions sometimes lead to bleeding into the lung. A patient having this condition feels movement of the blood caused by airflow in the lung during breathing, and perceives the blood as a foreign body and irritant. The patient coughs in an attempt to dislodge the perceived foreign body. Coughing blood, of course, is sometimes the first warning of a more serious disease or condition, but once that is realised, there is no benefit in such bleeding. Moreover, in such conditions where the lung might heal itself and subsequently stop bleeding, or indeed simply where the bleeding needs to be confined, the coughing reaction, which is almost impossible to resist, does not help the situation at all, and merely spreads the blood to other areas of the lung.
U.S. Pat. No. 5,382,261 discloses a vessel occluder for providing permanent occlusion of a vessel in a person by use of a flexible closure member attached to at least one radially expandable stent. The occluder does not have barbs or anchors or a stent.
DE-U-9205797 discloses a self expanding ‘meshbasket’ for the occlusion of human hollow organs. The invention is directed to female contraceptive devices and addresses the problem of remaining in place. The device may also find application in embolism therapy and vascular occlusion.
WO-A-9532018 discloses a body passageway closure for use in the occlusion of various passageways within the body, with particular application for the occlusion of blood vessels.
Therefore it is an object of the present invention to provide a method of treatment of certain lung conditions or diseases and to provide a device for such treatment.
In accordance with a first aspect of the present invention there is provided a method of treatment of emphysema or other lung conditions or diseases, the method comprising placing an obturator in a bronchial tube or tubule so as to seal the tube or tubule against the passage of fluid past the obturator.
In the case of emphysema, and by the simple expedient of inserting an obturator in a bronchial tube, a section of a lung can be isolated so that no air can be drawn into it. Thereafter, the isolated part deflates in time as the air remaining in it becomes absorbed, and so that part of the lung stops affecting other areas of the lungs, which can thus perform normally. Such a procedure is relatively simple, requiring only a delivery device for the obturator, which device is inserted through the mouth and airway of the patient until the proposed placement site is reached, whereupon the device is activated to release the obturator from the device.
In the case of bleeding into the lung, an obturator stops the flow of blood. The lung is tamponated by the obturator and blood merely collects in the isolated part of the lung and ultimately, if the bleeding stops, will be reabsorbed. Alternatively, in the case of some, perhaps terminal, conditions such as some lung cancers, it at least provides temporary relief for the patient.
In accordance with a second aspect of the invention there is provided the use of a blocking element and a securing element in the manufacture of an obturator for use in the treatment of a lung condition in a human or animal by blocking a bronchial tube or tubule. The condition may be emphysema.
Preferably the two elements are separate components, the blocking element serving to seal the tube or tubule against the passage of fluid past the obturator when the obturator is disposed in a bronchial tube or tubule, and the securing element serving to retain the blocking element in position in the tube or tubule.
The blocking element preferably comprises a substantially cylindrical plug of biocompatible material. The plug may comprise resiliently deformable closed-cell foamed plastics material, such as PVC, so that it may be compressed to facilitate insertion into the tube or tubule and thereafter expand to fill the cross-section of the tube or tubule.
It is known to employ stents in medical fields to expand and support collapsed blood vessels, and indeed bronchial tubes. A stent is a compressible framework which, when inserted into a vessel and released, expands and, within the limits of its expansion, supports and possibly expands the walls of the vessel.
Preferably, the securing element comprises a stent. The stent may have barbs to engage and retain the blocking element. The stent preferably also has anchors to retain the stent in a bronchial tube or tubule.
In one embodiment, the stent comprises a crown of surgical quality steel wire legs in zig-zag formation. Said barbs and anchors may depend from points of the crown. Preferably the crown is closed in its circumference, although this is not essential.
In another embodiment, the stent comprises a dome of surgical quality steel wire legs. Said barbs and anchors may be formed on the ends of said legs.
It is known in medical fields to block blood vessels, for example where a genetic or other defect has resulted in a hole which needs blocking, or, for example, in the case of babies whose aortic to pulmonary artery connection has not closed following birth, a condition known as patent ductus arteriosus. In the case of holes, it is well known to employ an “umbrella”, where a diaphragm of material forms the seal against the blood vessel wall, the handle of the umbrella serving to keep the diaphragm across the vessel. In the case of babies, it has also been known to employ a plug of PVC foam to treat patent ductus arteriosus, the plug encouraging clotting.
However, in the case of bronchial tubes and tubules a diaphragm seal has not been used yet, although its application cannot be entirely ruled out. For example, an umbrella device with a larger surface area of contact with the bronchial mucosa might be as effective.
In blood vessels a complete seal is seldom required because any leak soon blocks by the formation of a clot; something that would not happen in an airway of a lung. Secondly, airways are not always absolutely circular in section, so a circular diaphragm may not always make a good seal, at least around some parts of the circumference, unless it has capacity to expand in all radial directions and has a large contact area.
However, a complete seal is an absolute requirement of the present invention (at least over the period of a single breath), because without it, air can leak past during inhalation and pressurise the lung in just the same way, and perhaps even to a greater extent. More importantly, however, a patient with such an obturator in place can only feel its presence if there is movement of air around it to stimulate adjacent nerve endings. Once a patient can feel the obturator, there will be irresistible compulsion to cough which, if done excessively, may be sufficient to dislodge the obturator.
Thus it has been found that a very effective seal is achieved by the use of said cylindrical plug of foamed PVC (of the type commonly employed as earplugs). The effectiveness of this arrangement is probably due to the fact that any leakage path has to be a long one and there are thus numerous opportunities for it to close and seal about at least one closed circuit around the plug. Another reason is that a plug can mould itself to the shape of the tube or tubule, which is itself unlikely to be cylindrical, or, indeed, circular in cross-section.
Preferably, the method of the present invention employs an obturator of the type defined above.
The delivery device preferably comprises a delivery tube in which the obturator is received in a compressed state at a distal end thereof, a guide tube, which is capable of following a possibly tortuous path under the guidance of a surgeon from entry into the mouth of a patient, down the patient's trachea and one bronchus to a proposed delivery site in a bronchial tube or tubule, and which has a passage to receive the delivery tube therealong, and release means to eject the obturator from the delivery tube and guide tube.
The obturator needs to slide in the delivery tube during ejection and the stent provides a low friction surface of the obturator to facilitate such ejection.
It is feasible that the blocking and securing elements may be integrally formed from plastics material, and wherein the securing element comprises adhered or fused anchor elements on the blocking element.
It is also feasible that the securing element may comprise a memory metal which is released to its normal expanded shape by a physical parameter, for example, the passage of an electric current therethrough, once it has been inserted at the proposed location. Otherwise it is in the same form as the above described steel stent which relies on resilience for its expansion. The advantage of a memory metal device is that it requires no compression during insertion so that the delivery tube of the delivery device may be replaced by a simple guide rod to which it is connected.
The invention will be better understood from the following description of particular embodiments given as non-limiting examples. The description refers to the accompanying drawings, in which:
In the majority of patients suffering from emphysema, it frequently effects mainly the upper lobes 14 of the lungs, leaving the lower lobes 16 unaffected, or at least less affected. However, if no treatment is given to a patient, the expansion effect of the upper lobes as the condition develops presses on the lower lobes and reduces their capacity to perform efficiently. Lower lobe emphysema does occur in some patients, and in which event it is then the upper lobes which are compressed.
Thus the present invention suggests placing an obturator 50 in a bronchial tube or tubule to isolate the region of the lung supplied by that tube or tubule. Where the obturator is placed will be decided by the surgeon and will depend on the how localised the damaged region of lung is. That is to say, if the whole lobe is badly affected, then the obturator is placed in the lobar bronchus 22 supplying that lobe (as shown at 50 in
The above considerations equally apply when the condition being treated is not emphysema but some other condition which a doctor considers can usefully be treated by the method of the present invention. Such another condition is where a lung, or part of it is bleeding into the airway and an obturator isolates the bleeding region and inhibits coughing which may damage the lung further, or at least cause further discomfort to the patient.
As can be seen from
The stent 90 is constructed from a plurality of legs 91 of surgical grade stainless steel wire welded together such that when extended the stent appears as a series 90 b of connected ‘W’s, as shown in an unconnected disposition in
When the two ends of the stent are joined together, the stent 90 folds into a circular frame or crown, capable of encompassing the biocompatible block 92. The stent is constructed so as to be of a size slightly smaller (in its unstressed condition) than the block, so that its natural resilience squeezes the block slightly. On the other hand, the stent should be larger than the airway into which it is to be introduced so that it presses outwardly against the wall of the airway, and is incorporated into the mucosa of the air passage.
The legs 91 of the stent crown are fitted with both internal barbs 98 and external anchors 100. The barbs 98 embed themselves in the block 92 and secure the block to the stent 90. The anchors 100 are adapted to engage the walls of the patient's airways to hold the stent in position.
The barbs and anchors are joined to the stent crown by a welded joint between two adjacent legs 91. Barbs can alternate with anchors at the same end of the stent, or one end can have all barbs, while the other end has all anchors. Both arrangements are shown in
A different embodiment of obturator 50 b, also in accordance with the present invention, is shown in
The aforementioned obturators all rely on resilience of the steel to return the stent to its original shape once released from the delivery mechanism and so as to enable fitment in a narrower tubule than the unstressed size of the stent would otherwise allow. However, this requires prestressing the stent and keeping it stressed during delivery. Thus the present invention may find suitable application for memory metals, which only return to their original shape when some physical condition changes, for example, temperature rise or electrical current flow.
It is essential for the blocking device 92 to be comprised of a resiliently deformable material such as PVC foam as mentioned above. This enables the blocking device to be easily surrounded by the stent 90 and deformed into a compact structure, thereby enabling delivery of the block to its destination in the lung.
It is likewise essential that the block be capable of expanding and reforming into its original shape once deposited in the desired location in the lungs. It should be noted that the block is deformed and reformed in both an axial and a radial direction. It is the block 92 which seals a bronchial tube or tubule; mucous surrounds the block and forms a fluid tight seal. The presence of the stent around the block does not inhibit sealing in any way since the stent is essentially incorporated into the mucosa lining the airway.
Under compression, PVC foam has a high coefficient of friction which would prevent ejection from the delivery device as described above, if it was not surrounded by the stent 90, which offers a relatively low friction surface to the inside of delivery tube 76.
However, it is feasible that the block 92 could include a low friction surface to enable such ejection without the stent. Instead of the stent as described above, anchor means might be moulded in biocompatible plastics material as a crown, for example, on one end of the block, and either be adhered, fused or otherwise bound thereto.
The effectiveness of the device depends, to some extent, on the length of the block. Moreover, the block is required to be of a size which is both comfortable to the patient once expanded in the lung and which expands to completely obstruct the passage of air into the affected portions of the lung. The extended size of the block therefore ranges between 5 mm and 25 mm in length, and between 5 and 11 mm in diameter, depending on the size of the tube or tubule to be obturated.
Obturator 50 c shown in
Finally, as mentioned above, the obturator may be as shown at 50 d in
While the obturator and method of the present invention has been described with reference to human patients, animal patients may in certain circumstances also benefit.
|Brevet cité||Date de dépôt||Date de publication||Déposant||Titre|
|US2832078 *||17 oct. 1956||29 avr. 1958||Battelle Memorial Institute||Heart valve|
|US2981254 *||12 nov. 1957||25 avr. 1961||Vanderbilt Edwin G||Apparatus for the gas deflation of an animal's stomach|
|US3320972 *||16 avr. 1964||23 mai 1967||High Roy F||Prosthetic tricuspid valve and method of and device for fabricating same|
|US3445916 *||19 avr. 1967||27 mai 1969||Schulte Rudolf R||Method for making an anatomical check valve|
|US3657744 *||8 mai 1970||25 avr. 1972||Univ Minnesota||Method for fixing prosthetic implants in a living body|
|US3671979 *||23 sept. 1969||27 juin 1972||Univ Utah||Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve|
|US3788327 *||30 mars 1971||29 janv. 1974||Donowitz H||Surgical implant device|
|US3874388 *||12 févr. 1973||1 avr. 1975||Ochsner Med Found Alton||Shunt defect closure system|
|US4014318 *||22 mai 1975||29 mars 1977||Dockum James M||Circulatory assist device and system|
|US4056854 *||28 sept. 1976||8 nov. 1977||The United States Of America As Represented By The Department Of Health, Education And Welfare||Aortic heart valve catheter|
|US4084268 *||22 avr. 1976||18 avr. 1978||Shiley Laboratories, Incorporated||Prosthetic tissue heart valve|
|US4086665 *||16 déc. 1976||2 mai 1978||Thermo Electron Corporation||Artificial blood conduit|
|US4212463 *||17 févr. 1978||15 juil. 1980||Pratt Enoch B||Humane bleeder arrow|
|US4218782 *||19 mai 1978||26 août 1980||Biocoating Anpartsselskab||Heart valve prosthesis and method for the production thereof|
|US4222126 *||14 déc. 1978||16 sept. 1980||The United States Of America As Represented By The Secretary Of The Department Of Health, Education & Welfare||Unitized three leaflet heart valve|
|US4250873 *||17 avr. 1978||17 févr. 1981||Richard Wolf Gmbh||Endoscopes|
|US4302854 *||4 juin 1980||1 déc. 1981||Runge Thomas M||Electrically activated ferromagnetic/diamagnetic vascular shunt for left ventricular assist|
|US4339831 *||27 mars 1981||20 juil. 1982||Medtronic, Inc.||Dynamic annulus heart valve and reconstruction ring|
|US4477930 *||28 sept. 1982||23 oct. 1984||Mitral Medical International, Inc.||Natural tissue heat valve and method of making same|
|US4698294 *||12 sept. 1986||6 oct. 1987||E. I. Du Pont De Nemours And Company||Lamination of photopolymerizable film onto a substrate employing an intermediate nonphotosensitive liquid layer|
|US4710192 *||17 oct. 1986||1 déc. 1987||Liotta Domingo S||Diaphragm and method for occlusion of the descending thoracic aorta|
|US4732152 *||5 déc. 1985||22 mars 1988||Medinvent S.A.||Device for implantation and a method of implantation in a vessel using such device|
|US4759758 *||7 déc. 1984||26 juil. 1988||Shlomo Gabbay||Prosthetic heart valve|
|US4774942 *||28 août 1987||4 oct. 1988||Litton Systems, Inc.||Balanced exhalation valve for use in a closed loop breathing system|
|US4808183 *||3 juin 1980||28 févr. 1989||University Of Iowa Research Foundation||Voice button prosthesis and method for installing same|
|US4819664 *||17 févr. 1988||11 avr. 1989||Stefano Nazari||Device for selective bronchial intubation and separate lung ventilation, particularly during anesthesia, intensive therapy and reanimation|
|US4830003 *||17 juin 1988||16 mai 1989||Wolff Rodney G||Compressive stent and delivery system|
|US4832680 *||3 juil. 1986||23 mai 1989||C.R. Bard, Inc.||Apparatus for hypodermically implanting a genitourinary prosthesis|
|US4846836 *||3 oct. 1988||11 juil. 1989||Reich Jonathan D||Artificial lower gastrointestinal valve|
|US4850999 *||26 mai 1981||25 juil. 1989||Institute Fur Textil-Und Faserforschung Of Stuttgart||Flexible hollow organ|
|US4877025 *||6 oct. 1988||31 oct. 1989||Hanson Donald W||Tracheostomy tube valve apparatus|
|US4879998 *||6 mai 1988||14 nov. 1989||Litton Systems, Inc.||Balanced exhalation valve for use in a closed loop breathing system|
|US4934999 *||28 juil. 1988||19 juin 1990||Paul Bader||Closure for a male urethra|
|US4946463 *||10 avr. 1989||7 août 1990||Pioneering Technologies, Inc.||Vessel occluder|
|US4983177 *||3 janv. 1990||8 janv. 1991||Wolf Gerald L||Method and apparatus for reversibly occluding a biological tube|
|US4990151 *||18 sept. 1989||5 févr. 1991||Medinvent S.A.||Device for transluminal implantation or extraction|
|US4994069 *||2 nov. 1988||19 févr. 1991||Target Therapeutics||Vaso-occlusion coil and method|
|US5061274 *||4 déc. 1989||29 oct. 1991||Kensey Nash Corporation||Plug device for sealing openings and method of use|
|US5116360 *||27 déc. 1990||26 mai 1992||Corvita Corporation||Mesh composite graft|
|US5116564 *||10 oct. 1989||26 mai 1992||Josef Jansen||Method of producing a closing member having flexible closing elements, especially a heart valve|
|US5123919 *||21 nov. 1991||23 juin 1992||Carbomedics, Inc.||Combined prosthetic aortic heart valve and vascular graft|
|US5147370 *||12 juin 1991||15 sept. 1992||Mcnamara Thomas O||Nitinol stent for hollow body conduits|
|US5151105 *||7 oct. 1991||29 sept. 1992||Kwan Gett Clifford||Collapsible vessel sleeve implant|
|US5152770 *||22 mars 1991||6 oct. 1992||Ab Hepar||Implantable device for occluding a duct in the body of a living being|
|US5158548 *||24 juil. 1991||27 oct. 1992||Advanced Cardiovascular Systems, Inc.||Method and system for stent delivery|
|US5161524 *||2 août 1991||10 nov. 1992||Glaxo Inc.||Dosage inhalator with air flow velocity regulating means|
|US5246445 *||24 janv. 1992||21 sept. 1993||Instent Inc.||Device for the treatment of constricted ducts in human bodies|
|US5306234 *||23 mars 1993||26 avr. 1994||Johnson W Dudley||Method for closing an atrial appendage|
|US5352240 *||31 mai 1989||4 oct. 1994||Promedica International, Inc.||Human heart valve replacement with porcine pulmonary valve|
|US5358518 *||25 janv. 1993||25 oct. 1994||Sante Camilli||Artificial venous valve|
|US5366478 *||27 juil. 1993||22 nov. 1994||Ethicon, Inc.||Endoscopic surgical sealing device|
|US5382259 *||26 oct. 1992||17 janv. 1995||Target Therapeutics, Inc.||Vasoocclusion coil with attached tubular woven or braided fibrous covering|
|US5382261 *||1 sept. 1992||17 janv. 1995||Expandable Grafts Partnership||Method and apparatus for occluding vessels|
|US5392775 *||22 mars 1994||28 févr. 1995||Adkins, Jr.; Claude N.||Duckbill valve for a tracheostomy tube that permits speech|
|US5409019 *||3 nov. 1993||25 avr. 1995||Wilk; Peter J.||Coronary artery by-pass method|
|US5411507 *||5 janv. 1994||2 mai 1995||Richard Wolf Gmbh||Instrument for implanting and extracting stents|
|US5411552 *||14 juin 1994||2 mai 1995||Andersen; Henning R.||Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis|
|US5413599 *||13 déc. 1993||9 mai 1995||Nippon Zeon Co., Ltd.||Medical valve apparatus|
|US5417226 *||9 juin 1994||23 mai 1995||Juma; Saad||Female anti-incontinence device|
|US5445626 *||15 mai 1992||29 août 1995||Gigante; Luigi||Valve operated catheter for urinary incontinence and retention|
|US5453090 *||1 mars 1994||26 sept. 1995||Cordis Corporation||Method of stent delivery through an elongate softenable sheath|
|US5486154 *||8 juin 1993||23 janv. 1996||Kelleher; Brian S.||Endoscope|
|US5499995 *||25 mai 1994||19 mars 1996||Teirstein; Paul S.||Body passageway closure apparatus and method of use|
|US5500014 *||9 mai 1994||19 mars 1996||Baxter International Inc.||Biological valvular prothesis|
|US5562608 *||13 avr. 1995||8 oct. 1996||Biopulmonics, Inc.||Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation|
|US5588424 *||28 juin 1995||31 déc. 1996||The Cleveland Clinic Foundation||Bronchial blocker endotracheal apparatus|
|US5645519 *||18 mars 1994||8 juil. 1997||Jai S. Lee||Endoscopic instrument for controlled introduction of tubular members in the body and methods therefor|
|US5645565 *||13 juin 1995||8 juil. 1997||Ethicon Endo-Surgery, Inc.||Surgical plug|
|US5649906 *||19 janv. 1995||22 juil. 1997||Gory; Pierre||Method for implanting a removable medical apparatus in a human body|
|US5658330 *||25 avr. 1995||19 août 1997||Mcghan Medical Corp.||Molded silicone foam implant and method for making|
|US5660175 *||21 août 1995||26 août 1997||Dayal; Bimal||Endotracheal device|
|US5662713 *||14 sept. 1995||2 sept. 1997||Boston Scientific Corporation||Medical stents for body lumens exhibiting peristaltic motion|
|US5683451 *||7 juin 1995||4 nov. 1997||Cardiovascular Concepts, Inc.||Apparatus and methods for deployment release of intraluminal prostheses|
|US5697968 *||10 août 1995||16 déc. 1997||Aeroquip Corporation||Check valve for intraluminal graft|
|US5733329 *||30 déc. 1996||31 mars 1998||Target Therapeutics, Inc.||Vaso-occlusive coil with conical end|
|US5755770 *||31 janv. 1995||26 mai 1998||Boston Scientific Corporatiion||Endovascular aortic graft|
|US5803080 *||20 déc. 1996||8 sept. 1998||Willy Rusch Ag||Instrument for interventional flexible tracheoscopy/bronchoscopy|
|US5833707 *||5 juil. 1995||10 nov. 1998||Advanced Cardiovascular Systems, Inc.||Removable stent and method of deployment|
|US5840081 *||19 févr. 1997||24 nov. 1998||Andersen; Henning Rud||System and method for implanting cardiac valves|
|US5855587 *||22 août 1996||5 janv. 1999||Chon-Ik Hyon||Hole forming device for pierced earrings|
|US5855601 *||21 juin 1996||5 janv. 1999||The Trustees Of Columbia University In The City Of New York||Artificial heart valve and method and device for implanting the same|
|US5868704 *||26 juin 1996||9 févr. 1999||W. L. Gore & Associates, Inc.||Balloon catheter device|
|US5876445 *||26 nov. 1996||2 mars 1999||Boston Scientific Corporation||Medical stents for body lumens exhibiting peristaltic motion|
|US5919224 *||12 févr. 1997||6 juil. 1999||Schneider (Usa) Inc||Medical device having a constricted region for occluding fluid flow in a body lumen|
|US6022312 *||1 mai 1996||8 févr. 2000||Chaussy; Christian||Endosphincter, set for releasable closure of the urethra and method for introduction of an endosphincter into the urethra|
|US6027508 *||3 oct. 1996||22 févr. 2000||Scimed Life Systems, Inc.||Stent retrieval device|
|US6287290 *||2 juil. 1999||11 sept. 2001||Pulmonx||Methods, systems, and kits for lung volume reduction|
|US6398775 *||21 oct. 1999||4 juin 2002||Pulmonx||Apparatus and method for isolated lung access|
|US6527761 *||27 oct. 2000||4 mars 2003||Pulmonx, Inc.||Methods and devices for obstructing and aspirating lung tissue segments|
|US6585639 *||27 oct. 2000||1 juil. 2003||Pulmonx||Sheath and method for reconfiguring lung viewing scope|
|US6709401 *||2 juil. 2001||23 mars 2004||Pulmonx||Methods, systems, and kits for lung volume reduction|
|US6878141 *||28 juin 2000||12 avr. 2005||Pulmonx||Methods systems and kits for lung volume reduction|
|US6997918 *||4 mars 2003||14 févr. 2006||Pulmonx||Methods and devices for obstructing and aspirating lung tissue segments|
|US20020062120 *||13 déc. 2001||23 mai 2002||Pulmonx||Methods, systems, and kits for lung volume reduction|
|US20020077593 *||11 févr. 2002||20 juin 2002||Pulmonx||Apparatus and method for isolated lung access|
|US20040158228 *||26 janv. 2004||12 août 2004||Pulmonx||Methods, systems, and kits for lung volume reduction|
|US20050015106 *||20 août 2004||20 janv. 2005||Pulmonx||Methods, systems, and kits for lung volume reduction|
|US20050061322 *||3 nov. 2004||24 mars 2005||Pulmonx||Method and arrangement for reducing the volume of a lung|
|US20050203483 *||12 avr. 2005||15 sept. 2005||Pulmonx||Methods, systems, and kits for lung volume reduction|
|Brevet citant||Date de dépôt||Date de publication||Déposant||Titre|
|US7682332||30 juin 2004||23 mars 2010||Portaero, Inc.||Methods to accelerate wound healing in thoracic anastomosis applications|
|US7686013||12 févr. 2008||30 mars 2010||Portaero, Inc.||Variable resistance pulmonary ventilation bypass valve|
|US7726305||12 févr. 2008||1 juin 2010||Portaero, Inc.||Variable resistance pulmonary ventilation bypass valve|
|US7753052||6 févr. 2008||13 juil. 2010||Portaero, Inc.||Intra-thoracic collateral ventilation bypass system|
|US7789083||31 janv. 2008||7 sept. 2010||Portaero, Inc.||Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease|
|US7811274||27 avr. 2004||12 oct. 2010||Portaero, Inc.||Method for treating chronic obstructive pulmonary disease|
|US7824366||10 déc. 2004||2 nov. 2010||Portaero, Inc.||Collateral ventilation device with chest tube/evacuation features and method|
|US7828789||7 avr. 2008||9 nov. 2010||Portaero, Inc.||Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis|
|US7896008||6 août 2007||1 mars 2011||Portaero, Inc.||Lung reduction system|
|US7909803||18 févr. 2009||22 mars 2011||Portaero, Inc.||Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease|
|US7927324||18 févr. 2009||19 avr. 2011||Portaero, Inc.||Aspirator and method for pneumostoma management|
|US7931641||21 févr. 2008||26 avr. 2011||Portaero, Inc.||Visceral pleura ring connector|
|US8021320||18 févr. 2009||20 sept. 2011||Portaero, Inc.||Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma|
|US8029492||7 avr. 2008||4 oct. 2011||Portaero, Inc.||Method for treating chronic obstructive pulmonary disease|
|US8062315||12 févr. 2008||22 nov. 2011||Portaero, Inc.||Variable parietal/visceral pleural coupling|
|US8104474||23 août 2005||31 janv. 2012||Portaero, Inc.||Collateral ventilation bypass system with retention features|
|US8136520||14 janv. 2010||20 mars 2012||Pulmonx Corporation||Occlusion device|
|US8136526||7 mars 2007||20 mars 2012||Pulmonx Corporation||Methods and devices to induce controlled atelectasis and hypoxic pulmonary vasoconstriction|
|US8142455||12 sept. 2008||27 mars 2012||Pneumrx, Inc.||Delivery of minimally invasive lung volume reduction devices|
|US8157823||12 sept. 2008||17 avr. 2012||Pneumrx, Inc.||Lung volume reduction devices, methods, and systems|
|US8157837||2 juin 2006||17 avr. 2012||Pneumrx, Inc.||Minimally invasive lung volume reduction device and method|
|US8163034||21 févr. 2008||24 avr. 2012||Portaero, Inc.||Methods and devices to create a chemically and/or mechanically localized pleurodesis|
|US8220460||19 nov. 2004||17 juil. 2012||Portaero, Inc.||Evacuation device and method for creating a localized pleurodesis|
|US8231581||25 janv. 2011||31 juil. 2012||Portaero, Inc.||Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease|
|US8252003||18 févr. 2009||28 août 2012||Portaero, Inc.||Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease|
|US8282660||2 juil. 2008||9 oct. 2012||Pneumrx, Inc.||Minimally invasive lung volume reduction devices, methods, and systems|
|US8323230||20 janv. 2010||4 déc. 2012||Portaero, Inc.||Methods and devices to accelerate wound healing in thoracic anastomosis applications|
|US8336540||12 févr. 2009||25 déc. 2012||Portaero, Inc.||Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease|
|US8342182||27 août 2007||1 janv. 2013||Pulmonx Corporation||Functional assessment and treatment catheters and methods for their use in the lung|
|US8347880||18 févr. 2009||8 janv. 2013||Potaero, Inc.||Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease|
|US8347881||8 janv. 2010||8 janv. 2013||Portaero, Inc.||Pneumostoma management device with integrated patency sensor and method|
|US8348906||18 févr. 2009||8 janv. 2013||Portaero, Inc.||Aspirator for pneumostoma management|
|US8357139||4 nov. 2008||22 janv. 2013||Pulmonx Corporation||Methods and devices for use in performing pulmonary procedures|
|US8365722||18 févr. 2009||5 févr. 2013||Portaero, Inc.||Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease|
|US8430094||18 févr. 2009||30 avr. 2013||Portaero, Inc.||Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease|
|US8453637||18 févr. 2009||4 juin 2013||Portaero, Inc.||Pneumostoma management system for treatment of chronic obstructive pulmonary disease|
|US8453638||18 févr. 2009||4 juin 2013||Portaero, Inc.||One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease|
|US8464708||18 févr. 2009||18 juin 2013||Portaero, Inc.||Pneumostoma management system having a cosmetic and/or protective cover|
|US8474449||18 févr. 2009||2 juil. 2013||Portaero, Inc.||Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease|
|US8475389||8 juin 2010||2 juil. 2013||Portaero, Inc.||Methods and devices for assessment of pneumostoma function|
|US8491602||18 févr. 2009||23 juil. 2013||Portaero, Inc.||Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease|
|US8496006||22 juin 2010||30 juil. 2013||Pulmonx Corporation||Methods and devices for passive residual lung volume reduction and functional lung volume expansion|
|US8506577||6 juil. 2012||13 août 2013||Portaero, Inc.||Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease|
|US8518053||11 févr. 2010||27 août 2013||Portaero, Inc.||Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease|
|US8632605||11 sept. 2009||21 janv. 2014||Pneumrx, Inc.||Elongated lung volume reduction devices, methods, and systems|
|US8668707||14 sept. 2012||11 mars 2014||Pneumrx, Inc.||Minimally invasive lung volume reduction devices, methods, and systems|
|US8721734||18 mai 2010||13 mai 2014||Pneumrx, Inc.||Cross-sectional modification during deployment of an elongate lung volume reduction device|
|US8740921||14 sept. 2012||3 juin 2014||Pneumrx, Inc.||Lung volume reduction devices, methods, and systems|
|US8932310||14 sept. 2012||13 janv. 2015||Pneumrx, Inc.||Minimally invasive lung volume reduction devices, methods, and systems|
|US8986338||29 oct. 2009||24 mars 2015||Cook Biotech Incorporated||Vascular plugs|
|US9050094||19 mars 2009||9 juin 2015||Pulmonx Corporation||Methods and devices for passive residual lung volume reduction and functional lung volume expansion|
|US20040225254 *||27 avr. 2004||11 nov. 2004||Don Tanaka||Localized pleurodesis chemical delivery|
|US20040237966 *||20 mai 2004||2 déc. 2004||Don Tanaka||Methods and devices to assist pulmonary decompression|
|US20040244803 *||24 mai 2004||9 déc. 2004||Don Tanaka||Intra-thoracic collateral ventilation bypass system|
|US20050025816 *||30 juin 2004||3 févr. 2005||Don Tanaka||Methods and devices to accelerate wound healing in thoracic anastomosis applications|
|US20060107961 *||19 nov. 2004||25 mai 2006||Don Tanaka||Localized pleurodesis evacuation device|
|US20060118125 *||19 nov. 2004||8 juin 2006||Don Tanaka||Pulmonary drug delivery|
|US20060118126 *||19 nov. 2004||8 juin 2006||Don Tanaka||Methods and devices for controlling collateral ventilation|
|US20060124126 *||10 déc. 2004||15 juin 2006||Don Tanaka||Collateral ventilation device with chest tube/evacuation features|
|US20070051372 *||23 août 2005||8 mars 2007||Don Tanaka||Collateral ventilation bypass system with retention features|
|Classification aux États-Unis||606/157, 623/23.7|
|Classification internationale||A61B17/24, A61F2/86, A61B17/12|
|Classification coopérative||A61B17/12177, A61B17/12104, A61B17/12022, A61B2017/1205, A61B17/12172, A61B17/12159, A61B17/12136|
|Classification européenne||A61B17/12P7W1, A61B17/12P7B, A61B17/12P7W3, A61B17/12P7P, A61B17/12P5A, A61B17/12P|
|8 févr. 2007||AS||Assignment|
Owner name: EMPHASYS MEDICAL, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SABANATHAN, THIRUMANI;BRADFORD HOSPITALS NHS TRUST;FOUNDRY, LLC, THE;REEL/FRAME:018880/0210
Effective date: 20010720
Owner name: FOUNDRY, LLC, THE, CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SABANATHAN, THIRUMANI;BRADFORD HOSPITALS NHS TRUST;REEL/FRAME:018880/0051
Effective date: 20000606
Owner name: EMPHASYS MEDICAL, INC., CALIFORNIA
Free format text: SUPPLEMENT TO AGREEMENT OF JUNE 6, 2000.;ASSIGNOR:THIRUMANI SABANATHAN, BRADFORD HOSPITALS NHS TRUST AND THE FOUNDRY, LLC;REEL/FRAME:018880/0172
Effective date: 20010119
|21 juin 2009||AS||Assignment|
Owner name: PULMONX, CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EMPHASYS MEDICAL, INC.;REEL/FRAME:022852/0851
Effective date: 20090331